Concepedia

Publication | Open Access

METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

DOIFull Paper Access

130

Citations

0

References

2019

Year

L.L. Siu, Drew Rasco, S. P. Vinay, P. Martin Romano, Jessica Menis, Frans L. Opdam, Kimberley M. Heinhuis, Jacqueline L. Egger, Shelby Gorman, Ridhi Parasrampuria,
Annals of Oncology

No additional data available for this publication yet. Check back later!